Valuation: Hualan Biological Engineering Inc.

Capitalization 30.1B 4.12B 3.98B 3.76B 3.32B 5.89B 357B 6.54B 44.75B 16.61B 149B 15.44B 15.13B 627B P/E ratio 2024 *
22.2x
P/E ratio 2025 * 17.6x
Enterprise value 28.11B 3.85B 3.72B 3.51B 3.1B 5.5B 334B 6.11B 41.79B 15.51B 139B 14.42B 14.13B 586B EV / Sales 2024 *
5.47x
EV / Sales 2025 * 4.71x
Free-Float
52.69%
Yield 2024 *
1.73%
Yield 2025 * 1.98%
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.84%
1 week+4.11%
Current month+4.11%
1 month+4.24%
3 months-6.21%
6 months+4.05%
Current year-2.31%
More quotes
1 week
15.88
Extreme 15.88
16.65
1 month
15.50
Extreme 15.5
16.65
Current year
15.50
Extreme 15.5
16.95
1 year
13.72
Extreme 13.72
21.10
3 years
13.72
Extreme 13.72
26.43
5 years
13.72
Extreme 13.72
76.00
10 years
10.86
Extreme 10.859
76.00
More quotes
Director TitleAgeSince
Chief Executive Officer 53 2022-04-27
Director of Finance/CFO 57 2013-04-23
Chief Tech/Sci/R&D Officer 57 2013-04-23
Manager TitleAgeSince
Chairman 76 2007-04-11
Director/Board Member 53 2013-03-31
Director/Board Member 54 2022-04-27
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi.($)
-0.84%+4.11%-13.28%-37.30% 4.16B
-1.07%-5.89%-12.34%+4.45% 82.2B
+3.89%+17.40%+44.05%+51.29% 55.45B
-0.94%+1.94%+102.18%+116.90% 37.4B
-2.21%-2.18%-42.16%-35.04% 20.77B
-3.57%+7.23%+392.19%+798.22% 14.4B
+0.35%+0.52%+75.29%+140.63% 13.51B
-2.88%-10.51%+15.04%-0.64% 13.16B
+0.08%+1.08%-28.16%-30.10% 12.1B
-1.84%-2.83%+5.42%-36.66% 11.67B
Average -0.90%+0.24%+53.82%+97.18% 26.48B
Weighted average by Cap. -0.21%+1.19%+41.18%+72.86%
See all sector performances

Financials

2024 *2025 *
Net sales 5.14B 703M 679M 641M 566M 1.01B 60.99B 1.12B 7.63B 2.83B 25.34B 2.63B 2.58B 107B 6.1B 835M 807M 762M 672M 1.19B 72.47B 1.33B 9.07B 3.37B 30.11B 3.13B 3.07B 127B
Net income 1.36B 186M 180M 170M 150M 267M 16.17B 296M 2.02B 751M 6.72B 698M 685M 28.38B 1.69B 231M 224M 211M 186M 331M 20.08B 368M 2.51B 933M 8.34B 867M 850M 35.24B
Net Debt -1.99B -272M -263M -249M -219M -390M -23.65B -433M -2.96B -1.1B -9.82B -1.02B -1B -41.49B -1.37B -188M -182M -171M -151M -269M -16.3B -298M -2.04B -757M -6.77B -704M -690M -28.61B
More financial data * Estimated data
Logo Hualan Biological Engineering Inc.
Hualan Biological Engineering, Inc. specializes in the research, development, manufacturing and marketing of biological and sanguine products and vaccines. The group's products include immunoglobulin for intravenous injections, lyophilized surgical fibrin, lyophilized thrombin for external use, vaccines against cold, etc.
Employees
3,709
Calendar
More about the company
Date Price Change Volume
25-02-11 16.46 ¥ -0.84% 8,574,127
25-02-10 16.60 ¥ +1.90% 11,586,160
25-02-07 16.29 ¥ -0.06% 10,909,890
25-02-06 16.30 ¥ -0.49% 9,537,435

End-of-day quote Shenzhen S.E., February 10, 2025

More quotes
Trading Rating
Investor Rating
ESG MSCI
CCC
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
16.46CNY
Average target price
20.70CNY
Spread / Average Target
+25.74%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. 002007 Stock